Insulinorezistentnost' i izbytochnaya massa telau patsientki s prolaktinsekretiruyushchey adenomoy gipofiza

1. Дедов И.И., Мельниченко Г.А., Романцова Т.И. Синдром гиперпролактинемии. - М., 2004.

2. Курляндская Р.И., Романцова Т.И. Влияние гиперпролактинемии на основные показатели жирового обмена. // Лечащий врач. - 2004. - № 1.

3. Abech D.D., Moratelli H.B., Leite S.C., Oliveira M.C. Effects of estrogen replacement therapy on pituitary size, prolactin and thyroid-stimulating hormone concentrations in menopausal women. // Gynecol Endocrinol. - 2005. - Vol. 21. № 4. - P. 223-236.

4. Bahceci M., Tuzcu A., Bahceci S., Tuzcu S. Is hyperprolactinemia associated with insulin resistance in non-obese patients with polycystic ovary syndrome? // J Endocrinol Invest. - 2003. - Vol. 26. N. 7. - P. 655-659.

5. Baptista T., Lacruz A., Meza T., Contreras Q., Delgado C., Mejas M.A., Hernndez L. Antipsychotic drugs and obesity: is prolactin involved? //Can J Psychiatry. - 2001. - Vol. 46. N 9. - P. 829-834.

6. Ben-Jonathan N., Hugo E.R., Brandebourg T.D., LaPensee C.R. Focus on prolactin as a metabolic hormone. // Trends Endocrinol Metab. - 2006. - Vol. 17. № 3. - P. 110-116

7. Brandebourg T.D., Bown J.L., Ben-Jonathan N. Prolactin upregulates its receptors and inhibits lipolysis and leptin release in male rat adipose tissue. // Biochem Biophys Res Commun. - 2007. - Vol. 357. № 2. - P. 408-413.

8. Christin-Ma tre S., Delemer B., Touraine P., Young J. Prolactinoma and estrogens: pregnancy, contraception and hormonal replacement therapy. //Ann Endocrinol (Paris). - 2007 - Vol. 68. № 2-3. - P.106-112.

9. Doknic M., Pekic S., Zarkovic M., Medic-Stojanoska M., Dieguez C., Casanueva F., Popovic V. Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine. // Eur J Endocrinol. - 2002. - Vol. 147. № 1. - P. 77-84.

10. Fleenor D.E., Freemark M. Prolactin induction of insulin gene transcription: roles of glucose and signal transducer and activator of transcription 5. // Endocrinology. - 2001. - Vol. 142. № 7. - P. 2805-2810. Литература

11. Fleenor D., Arumugam R., Freemark M. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I. // Horm Res. - 2006. - Vol. 66. № 3. - P. 101-110.

12. Greenman Y., Tordjman K., Stern N. Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels. // Clin Endocrinol (Oxf). - 1998. - Vol.48. № 5. - P. 547-553.

13. Heil S.H. Sex-specific effects of prolactin on food intake by rats. // Horm Behav. - 1999. - Vol. 35. № 1. - P. 47-54.

14. Ling C., Billig H. PRL receptor-mediated effects in female mouse adipocytes: PRL induces suppressors of cytokine signaling expression and suppresses insulin-induced leptin production in adipocytes in vitro. // Endocrinology. - 2001. - Vol. 142. № 11. -P.480-490.

15. McAveney K.M., Gimble J.M., Yu-Lee L.-Y. Prolactin receptor expression during adipocyte differentiation of bone marrow stroma. // Endocrinology. - 1996. - № 137. - P. 5723-5726.

16. Moore B.J., Gerardo-Gettens T., Horwitz B.A., Stern J.S. Hyperprolactinemia stimulates food intake in the female rat. // Brain Res Bull. - 1986. - Vol. 17. № 4. - P. 563-569.

17. Pelkonen R., Nikkil E.A., Grahne B. Serum lipids, postheparin plasma lipase activities and glucose tolerance in patients with prolactinoma. // Clin Endocrinol (Oxf). - 1982. - Vol. 16. № 4. - P. 383-390.

18. Tuzcu A., Bahceci M., Dursun M., Turgut C., Bahceci S. Insulin sensitivity and hyperprolactinemia. // J Endocrinol Invest. - 2003. - Vol. 26. № 4. - P. 341-346